Our current economic landscape makes it challenging to find the right job candidates for hiring. Consider the trends in marijuana… The post Express Results® Confirmable – the evolution of instant oral fluid testing is here! appeared first on Quest Diagnostics Workforce Health Solutions Blog ..read more

In today’s fast-paced world, instant results matter more than ever. Our newest instant oral drug testing, Express Results® Confirmable, provides… The post Why is implementing Express Results Confirmable instant oral fluid solution a smart choice? appeared first on Quest Diagnostics Workforce Health Solutions Blog ..read more

As a leader in the field of workplace safety solutions, we are excited to introduce our latest product, Express Results®… The post Instant oral fluid testing from Quest is now here! appeared first on Quest Diagnostics Workforce Health Solutions Blog ..read more

Learn how integrating diagnostic testing into HR practices yields actionable insights, fostering informed decision-making and optimizing workforce management In the contemporary workspace, the paradigm of employee health and wellness benefits is rapidly evolving. No longer confined to traditional health coverage, employers are prioritizing the inclusion of comprehensive, high-quality diagnostic testing within their wellness programs. This shift underscores an enlightened approach to preventive care, reflecting a broader organizational commitment to not only safeguarding employee health but al ..read more

The Quest Diagnostics Drug Testing Index (DTI) is an essential report, considered a valuable tool for workforce drug testing industry trends since its inception in 1988. It examines positivity rates, providing a comprehensive analysis of workplace drug use trends among federally mandated, safety-sensitive workers, the general US workforce, and the combined US workforce. When it comes to understanding historical patterns of drug use among American workers, the DTI is the industry standard. Employers benefit from having more tools, like the Quest Diagnostics Drug Testing Index from one provider ..read more

Even though oral fluid drug testing has been around for more than 2 decades, it appears that many employers are taking it seriously for the first time. For instance, in a 2023 survey of workforce drug testing providers, 87% reported offering oral fluid testing, compared to 39% in 2019. When asked what drug testing method will be most used in the future, 46% said oral fluid testing, in 2019, the same percentage indicated urine testing would be used most often.[1] Employers must manage an often-overwhelming number of benefits and vendor partnerships, so a streamlined solution can both save lead ..read more

As an employer, you are likely trying to balance the creation of a safe and productive workplace while also providing meaningful benefits for your employees—offerings that help keep them healthy and engaged at work—with minimizing spending. It’s not an easy task, especially today when employees have more stressors than ever before and it’s often a challenge to know the ROI on those benefits. Additionally, within your workforce, healthcare needs may vary greatly. Employers must manage an often-overwhelming number of benefits and vendor partnerships, so a streamlined solution can both save ..read more

In the dynamic landscape of workplace health, the integration of population health and workforce drug testing solutions marks a significant stride toward comprehensive employee well-being. Employers are facing steadily rising healthcare costs, with annual health plan increases of 9% to 10% predicted through 2026.1 These cost pressures are leading employers to rethink their benefit structures. Today’s employers are focused on how they can address healthcare costs while managing the wellness benefits employees want and providing the access to care they need. An estimated 70% of employers believ ..read more

As 2023 draws to an end, employers in California and Washington are facing important decisions on marijuana drug testing based on laws AB2188 (California) and SB5123 (Washington) which go into effect on January 1, 2024. These new laws will prohibit employers, in some instances, from taking adverse action against an employee or applicant based on marijuana drug testing results for “non-psychoactive metabolite(s)”. In California, the new law applies to both pre- and post-employment drug testing, whereas in Washington it only applies to pre-employment drug testing. “The good news is employers wh ..read more

The opioid epidemic continues to be a public health emergency. Data from the Centers for Disease Control and Prevention (CDC) paint a stark picture – the number of deaths from a drug overdose in 2021 was over 6 times the number in 1999. Overdose deaths increased by 16% from 2020-2021, and of the nearly 110,000 overdose deaths in 2021, over 75% of them can be attributed to opioids. According to the Drug Enforcement Agency, Fentanyl is a potent synthetic opioid drug approved by the Food and Drug Administration for use for pain relief and anesthetic. It is approximately 100 times more poten ..read more